Cell Viability Assays Market to Grow at a CAGR of 9.9% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Cell Viability Assays Market Size During 2025–2029?

The cell viability assays market has experienced substantial growth recently. It is forecast to grow from $1.56 billion in 2024 to $1.73 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.5%. The expansion observed in past periods can be attributed to increased investment in cancer research, rising pharmaceutical R&D expenditure, the burgeoning biotechnology sector, advanced cell culture techniques, a surge in demand for stem cell research, an escalated need for toxicity testing, broader utilization of real-time cell analysis systems, and an increase in contract research organizations (CROs).

The cell viability assays market is projected for significant expansion over the coming years, reaching “$2.52 billion in 2029, with a compound annual growth rate (CAGR) of 9.9%. This anticipated growth is driven by several factors, including the rising need for personalized and precision medicine, increased government investment in cell-based research, the expansion of stem cell research and its applications, a greater availability of automated cell viability analyzers, an uptick in infectious disease cases, a heightened emphasis on enhancing assay accuracy and sensitivity, broader understanding of the advantages of these assays, the emergence of organ-on-a-chip technologies, and the growing demand for regenerative medicine. Key trends during this period are expected to involve improvements in high-throughput screening techniques, the integration of AI and machine learning, the creation of real-time monitoring solutions, the widespread use of automated liquid handling systems, the creation of multiplex assays for concurrent cell viability measurement, the shift towards more sustainable and environmentally friendly reagents, the design of user-friendly assay kits, progress in electrochemical assays, the deployment of scalable cell viability assays, and the development of assays suitable for primary cells and stem cells.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16014&type=smp

Which Industry Drivers Are Expected To Accelerate The Cell Viability Assays Market From 2025 To 2029?

The projected expansion of cell-based therapeutics is anticipated to drive the advancement of the cell viability assay market in the future. These therapeutics involve medical interventions utilizing living cells to mend or substitute impaired tissue, combat illnesses, or re-establish typical bodily functions. The development of cell-based therapeutics is propelled by progress in biotechnology, rising investments in regenerative medicine, broader acceptance and implementation of cell therapies, and enhancements in cell engineering and production methods. Cell viability assays are crucial for cell-based therapeutics as they guarantee the vitality, operational capability, and secure nature of therapeutic cells, thus improving the effectiveness of treatments and maintaining quality control. An example provided by the American Society of Gene & Cell Therapy, a non-profit medical and scientific body based in the US, indicates that 38 trials for non-genetically modified cell therapies commenced in Q1 2023, representing an increase of 7 trials compared to the preceding quarter, Q4 2022. Consequently, the expansion of cell-based therapeutics is fueling the growth within the cell viability assay market.

What Are The Segment Types Shaping The Cell Viability Assays Market?

The cell viability assaysmarket covered in this report is segmented –

1) By Product: Consumables; Instruments

2) By Application: Basic Research; Stem Cell Research; Drug Discovery And Development; Clinical And Diagnostic Applications; Other Applications

3) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Hospital And Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Consumables: Reagents; Kits; Assay Plates (96-Well plates); Microplates

2) By Instruments: Spectrophotometers; Fluorometers; Microplate Readers; Flow Cytometers; Imaging Systems

What Trends Are Redefining The Cell Viability Assays Market Dynamics?

Leading companies engaged in the cell viability assays market are developing innovative cell screening technologies to enhance accuracy and expedite drug discovery. Cell screening technologies boost cell viability assays by enabling high-throughput, precise, and rapid assessments of cell health and responses, thereby optimizing experimental conditions and advancing the creation of therapeutic strategies. For instance, in May 2024, Arralyze, a technology company based in Germany, launched CellShepherd, a cutting-edge platform designed for single-cell analysis. This system utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time observation. The autonomous setup provides accurate cell dispensing, sterile co-culturing, and imaging through brightfield and fluorescent channels. Its AI-driven analysis guarantees precise cell counting and tracking. This user-friendly platform addresses the growing requirement for accurate single-cell research in biomedical and life science applications.

Who Are The Core Companies Influencing The Cell Viability Assays Market Landscape?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cell-viability-assays-global-market-report

What Regional Growth Trends Are Shaping The Cell Viability Assays Market Outlook?

North America was the largest region in the cell viability assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cell Viability Assays Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16014&type=smp

Browse Through More Reports Similar to the Global Cell Viability Assays Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Stem Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cellulars Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795